Technology
Latest news, analysis, and updates in technology.

$150 Price Cut Sends Nanoleaf Blocks to New Low for Dorms
Nanoleaf Blocks Combo XL just fell to $99.99, a new low for a smart light kit that also adds pegboard and shelf storage.

Outsourced Thinking Triggers Satya Nadella AI Warning
Satya Nadella says companies handing one AI lab their prompts, metadata and memory risk outsourcing the thinking that keeps them alive.

RAM Shock Slams Framework Laptop 13 Pro With $800 Hike
Framework built its best repairable laptop yet, but an $800 RAM-driven price jump may scare off the buyers it needs.

A $9 Autonomous Key Turns App Addiction Into Real Work
Autonomous Key uses a $9 NFC fob to make addictive apps harder to reopen, betting tiny friction can beat reflexive scrolling.

Samsung QD-OLED Monitor Crashes Below $300 in Rare Deal
Samsung’s 27-inch G50SF QD-OLED monitor fell to $299.99, pushing premium OLED gaming into midrange pricing.

466% CXMT Stock Debut Mints Chinese $484B RAM Giant
CXMT's 466% Shanghai debut turned a RAM maker into a $484B chip heavyweight overnight.

Snapchat Now Playing Turns Spotify Into Snap Map Status
Snapchat Now Playing turns Spotify into a live Snap Map status, giving 450 million monthly Map users a new way to share music.

$70M Seed Thrusts Enigma Robot Control Into Public Test
Enigma raised $70M to test a UX-first robot control system, starting with a public experiment across Israel and California.

Private Equity Puts NHS Patient Records System in TPG Hands
TPG's £300m Optum UK deal puts EMIS, used by most English GP practices, under private equity control.

Access Race Grips European Technology Network After $1.6M
European Technology Network's $1.6M raise turns a daily tech show into Europe's newest startup access stage.

AusAlert Test Jolts Cinemas but Leaves Phones Silent
AusAlert reached 94% of targeted towers, but some switched-on phones stayed silent, exposing gaps before the October rollout.

FDA Peptide Rule Changes Risk Telehealth Cash Grab
FDA peptide rule changes could turn a gray peptide market into a telehealth gold rush before the science catches up.